Skip to content
TrackPodcasts
newsApr 18, 20261:09

Trump Speeds Up Psychedelic Drug Research

About this episode

President Trump expedites psychedelic drug research, following a text exchange with Joe Rogan. The executive order aims to fast-track FDA approvals, potentially revolutionizing mental health care for veterans and those with severe depression.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/d4697be3d106ef37

Get every episode summarized

Each time UK News Today | 2 Min News | The Daily News Now! publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Transcript ready

19 searchable segments. Every word is indexed and playable.

Trump Speeds Up Psychedelic Drug Research

UK News Today | 2 Min News | The Daily News Now!

0:00
1:09

Full transcript

UK News Today | 2 Min News | The Daily News Now!Trump Speeds Up Psychedelic Drug Research. Machine-transcribed; use the interactive transcript above to jump the player to any line.

On April 18, President Trump just signed an executive order to speed up research on psychedelic drugs, like I will gain in LSD. It all kicked off from a simple text message with Joe Rogan, turning into federal policy in days. That text exchange lit a fire under the administration. Rogan said Trump replied super quick, something like sounds great, let's get FDA approval. By Saturday afternoon, they were in the Oval Office, making it official, with Health Secretary Robert F. Kennedy, Jr., and others pushing the effort, behind the scenes, folks are buzzing about the potential here. Trump highlighted how these treatments could change lives for people with severe depression and mental illness, especially veterans. A former Navy SEAL even told him it saved his life, and groups have been advocating for Ibogaine to help with trauma. The order tells the FDA to fast-track breakthrough therapies with priority vouchers, cutting review times from months to weeks. It also pushes data sharing across agencies, and could lead to rescheduling these long-band

substances. This move marks a huge policy flip, opening doors to treatments that might just transform mental health care if the science pans out.

More episodes

More from UK News Today | 2 Min News | The Daily News Now!

View all episodes →